초록 ▼

Disclosed is a dry composition, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste forms spontaneously upon addition of the liquid, hence no mechanical mixing is required for said paste to form. Further disclosed are

Disclosed is a dry composition, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste forms spontaneously upon addition of the liquid, hence no mechanical mixing is required for said paste to form. Further disclosed are methods of preparing said dry composition, a paste made from said dry composition and use of said paste for medical and surgical purposes.

대표청구항 ▼

1. A method of preparing a dry composition suitable for use in haemostasis and wound healing, comprising the sequential steps of: a) providing a cross-linked biocompatible polymer in powder form, one or more polyols and an aqueous medium, wherein the one or more polyols are selected from sugar alcoh

1. A method of preparing a dry composition suitable for use in haemostasis and wound healing, comprising the sequential steps of: a) providing a cross-linked biocompatible polymer in powder form, one or more polyols and an aqueous medium, wherein the one or more polyols are selected from sugar alcohols and sugars;b) mixing the biocompatible polymer, the one or more polyols and the aqueous medium to obtain a paste; andc) freeze-drying the paste to produce a dry composition, wherein the dry composition is capable of reconstituting to form a substantially homogeneous paste without mechanical mixing, wherein the dry composition comprises from 10% w/w to 60% w/w of one or more polyols. 2. The method according to claim 1, wherein the paste prior to drying comprises from 3% w/w to 20% w/w of one or more polyols. 3. The method according to claim 1, wherein the biocompatible polymer is gelatine. 4. The method according to claim 3, wherein the gelatine is obtained from a cross-linked gelatine sponge. 5. The method according to claim 1, wherein the paste prior to freeze-drying comprises: a) from 5% w/w to 20% w/w of one or more polyols;b) from 15% w/w to 25% w/w of biocompatible polymer; andc) from 60% w/w to 80% w/w of water. 6. The method according to claim 1, wherein the dry composition comprises less than 5% w/w of water. 7. The method according to claim 1, wherein the one or more sugar alcohols is selected from glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, dulcitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol or polyglycitol. 8. The method according to claim 1, wherein the one or more polyols is mannitol. 9. The method according to claim 8, where the dry composition comprises one or more further polyols. 10. The method according to claim 1, wherein the dry composition further comprises one or more bioactive agents that stimulate haemostasis or wound, bone, tendon and/or tissue healing. 11. The method according to claim 10, wherein the bioactive agent is thrombin. 12. The method according to claim 1, wherein the aqueous medium is selected from water, saline, a calcium chloride solution or a buffered aqueous medium. 13. The method according to claim 1, wherein the method comprises a further step of placing the dry composition into an outer packaging. 14. The method according to claim 13, wherein the outer packaging is an aluminium foil packaging. 15. The method according to claim 1, wherein the method comprises a further step of sterilising the dry composition. 16. The method according to claim 1, wherein the paste is filled into and freeze-dried within a syringe or applicator suitable for dispensing flowable haemostatic compositions. 17. The method according to claim 1, wherein the dry composition comprises from 20% w/w to 60% w/w of one or more polyols. 18. The method according to claim 1, wherein the dry composition comprises from 25% w/w to 60% w/w of one or more polyols. 19. A method for reconstituting a dry composition suitable for use in haemostasis and wound healing, comprising the sequential steps of: a) providing a cross-linked biocompatible polymer in powder form, one or more polyols and an aqueous medium, wherein the one or more polyols are selected from sugar alcohols and sugars;b) mixing the biocompatible polymer, the one or more polyols and the aqueous medium to obtain a paste;c) freeze-drying the paste to produce a dry composition, wherein the dry composition is capable of reconstituting to form a substantially homogeneous paste without mechanical mixing, wherein the dry composition comprises from 10% w/w to 60% w/w of one or more polyols; andd) adding an aqueous medium to the dry composition, thereby forming a paste without the need for mechanical mixing. 20. The method according to claim 19, wherein the dry composition is present in a container. 21. The method according to claim 20, wherein the container is a syringe.